• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. CONSERVE® FEMORAL RESURFACING HEAD 44MM; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. CONSERVE® FEMORAL RESURFACING HEAD 44MM; HIP COMPONENT Back to Search Results
Model Number 38031044
Device Problem Output Problem (3005)
Patient Problems Hair Loss (1877); Metal Related Pathology (4530)
Event Type  Injury  
Event Description
Allegedly, patient underwent bilateral hip resurfacing in two separate surgeries in 2018.Patient has recently contacted the hospital with, complaint of extremely high blood levels of cobalt (200nmol/l) and chromium (300nmol/l) whereas the normal level for a person with an implant is supposed to be less than or equal to 5nmol/l.The patient has been suffering from worsening tinnitus, insomnia, fatigue, hair loss, anxiety and skin issues.The patient is also well aware of the damage to the internal organs due to such toxic levels of these metals in the blood.The surgeries were performed by a canadian surgeon who used to be resident in dubai for more than 15 years.There has not been indicated which patient side is causing the patient to have these issues.No revision surgery has yet been indicated.Right-sided implanted devices are captured under microport orthopedics reference number: (b)(4).
 
Event Description
Allegedly, patient underwent bilateral hip resurfacing in two separate surgeries in 2018.Patient has recently contacted the hospital with complaint of extremely high blood levels of cobalt (200nmol/l) and chromium (300nmol/l) whereas the normal level for a person with an implant is supposed to be less than or equal to 5nmol/l.The patient has been suffering from worsening tinnitus, insomnia, fatigue, hair loss, anxiety and skin issues.The patient is also well aware of the damage to the internal organs due to such toxic levels of these metals in the blood.The surgeries were performed by a canadian surgeon who used to be resident in dubai for more than 15 years.There has not been indicated which patient side is causing the patient to have these issues.Right-sided implanted devices are captured under microport orthopedics reference number: (b)(6).Additional information received on 10/13/2022: it was indicated that the patient has been revised.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSERVE® FEMORAL RESURFACING HEAD 44MM
Type of Device
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
Manufacturer (Section G)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
Manufacturer Contact
5677 airline road
arlington, TN 38002
9018674771
MDR Report Key15543389
MDR Text Key301188956
Report Number3010536692-2022-00349
Device Sequence Number1
Product Code KXA
UDI-Device IdentifierM684380310441
UDI-PublicM684380310441
Combination Product (y/n)N
PMA/PMN Number
K944752
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/05/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model Number38031044
Device Catalogue Number38031044
Device Lot Number0786252431664689
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date09/12/2022
Date Manufacturer Received09/12/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient SexFemale
-
-